Designer adiponectin receptor agonist stabilizes metabolic function and prevents brain injury caused by HIV protease inhibitors

Journal of Neuroimmune Pharmacology

Volumn 9, Issue 3, 2014, Pages 388-398

  Pepping, Jennifer K ^a,b   Otvos, Laszlo ^c   Surmacz, Eva ^d   Gupta, Sunita ^a   Keller, Jeffrey N ^a   Bruce Keller, Annadora J ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c Temple University   (United States)

^d TEMPLE UNIVERSITY   (United States)

Author keywords

HIV protease inhibitors; HIV associated neurocognitive disorder; Lipodystrophy; Metabolic syndrome; Peptide based drugs

Indexed keywords

ADIPONECTIN RECEPTOR; ADP 355; LOPINAVIR PLUS RITONAVIR; PEPTIDOMIMETIC AGENT; UNCLASSIFIED DRUG; ADIPONECTIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG TARGETING; HIV ASSOCIATED DEMENTIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; HYPOADIPONECTINEMIA; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS FAT; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN INJURIES; C57BL MOUSE; CHEMICALLY INDUCED; CHEMISTRY; DRUG DESIGN; METABOLISM; TOXICITY;

ADIPONECTIN; ANIMALS; BRAIN INJURIES; DRUG DESIGN; HIV PROTEASE INHIBITORS; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, ADIPONECTIN;

EID: 84901283866     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-014-9529-1     Document Type: Article

References (59)

1. Ances BM, Ellis RJ (2007) Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 27:86-92 (Pubitemid 46239043)
2. Anuurad E, Semrad A, Berglund L (2009) Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease. Metab Syndr Relat Disord 7:401-410
3. Arai Y, Takayama M, Abe Y, Hirose N (2011) Adipokines and aging. J Atheroscler Thromb 18:545-545
4. Arama V, Tiliscan C, Streinu-Cercel A, Ion D, Mihailescu R, Munteanu D, Hristea A, Arama SS, group. S-As (2013) Insulin resistance and adipokines serum levels in a caucasian cohort of hiv-positive patients undergoing antiretroviral therapy: a cross sectional study. BMC Endocr Disord 13:4
5. Bandaru VV, McArthur JC, Sacktor N, Cutler RG, Knapp EL, Mattson MP, Haughey NJ (2007) Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology 68:1481-1487 (Pubitemid 46685918)
6. Barbaro G (2007) Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome. Curr Pharm Des 13:2208-2213
7. Chen B, Liao WQ, Xu N, Xu H, Wen JY, Yu CA, Liu XY, Li CL, Zhao SM, Campbell W (2009) Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res 1273:129-137
8. de Waal R, Cohen K, Maartens G (2013) Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction. PLoS One 8: e63623
9. Duntas LH, Popovic V, Panotopoulos G (2004) Adiponectin: novelties in metabolism and hormonal regulation. Nutr Neurosci 7:195-200 (Pubitemid 40123571)
10. Foley J, Ettenhofer M, Wright MJ, Siddiqi I, Choi M, Thames AD, Mason K, Castellon S, Hinkin CH (2010) Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age. Clin Neuropsychol 24:265-285
11. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation inmuscle and causes weight loss inmice. ProcNatl Acad Sci U S A 98:2005-2010 (Pubitemid 32165613)
12. Fry M, Smith PM, Hoyda TD, Duncan M, Ahima RS, Sharkey KA, Ferguson AV (2006) Area postrema neurons are modulated by the adipocyte hormone adiponectin. J Neurosci 26:9695-9702 (Pubitemid 44427708)
13. Gil A, Olza J, Gil-Campos M, Gomez-Llorente C, Aguilera CM (2011) Is adipose tissue metabolically different at different sites? Int J Pediatr Obes 6(Suppl 1):13-20
14. Guaraldi G, Zona S, Alexopoulos N, Orlando G, Carli F, Ligabue G, Fiocchi F, Lattanzi A, Rossi R, Modena M, Esposito R, Palella F and Raggi P (2009) Coronary aging in HIV-infected patients. 49:1756-1762
15. Gupta S, Knight AG, Losso BY, Ingram DK, Keller JN, Bruce-Keller AJ (2012) Brain injury caused by HIV protease inhibitors: role of lipodystrophy and insulin resistance. Antiviral Res 95:19-29
16. Gutierrez AD, Balasubramanyam A (2012) Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management. Endocrine 41:1-10
17. Han S, Hong S, Lee D, Lee MH, Choi JS, Koh MJ, Sun W, Kim H, Lee HW (2012) Altered expression of synaptotagmin 13mRNA in adult mouse brain after contextual fear conditioning. Biochem Biophys Res Commun 425:880-885
18. Harvey J (2007) Leptin regulation of neuronal excitability and cognitive function. Curr Opin Pharmacol 7:643-647
19. Jiménez-Nácher I, Alvarez E, Morello J, Rodriguez-Nóvoa S, de Andrés S, Soriano V (2011) Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients. Expert Opin Drug Metab Toxicol 7:457-477
20. Jung TW, Lee JY, Shim WS, Kang ES, Kim JS, Ahn CW, Lee HC, Cha BS (2006) Adiponectin protects human neuroblastoma SH-SY5Y cells against MPP + -induced cytotoxicity. Biochem Biophys Res Commun 343:564-570
21. Kamogawa K, Kohara K, Tabara Y, Uetani E, Nagai T, Yamamoto M, Igase M, Miki T (2010) Abdominal fat, adipose-derived hormones and mild cognitive impairment: the J-SHIPP study. Dement Geriatr Cogn Disord 30:432-439
22. Kinlaw WB, Marsh B (2004) Adiponectin and HIV-lipodystrophy: taking HAART. Endocrinology 145:484-486 (Pubitemid 38183789)
23. Kohli R, Shevitz A, Gorbach S, Wanke C (2007) A randomized placebocontrolled trial ofmetformin for the treatment of HIV lipodystrophy. HIV Med 8:420-426 (Pubitemid 47335264)
24. Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, Kozono H, Takamoto I, Okamoto S, Shiuchi T, Suzuki R, Satoh H, Tsuchida A, Moroi M, Sugi K, Noda T, Ebinuma H, Ueta Y, Kondo T, Araki E, Ezaki O, Nagai R, Tobe K, Terauchi Y, Ueki K, Minokoshi Y, Kadowaki T (2007) Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 6: 55-68 (Pubitemid 47007437)
25. Leszczyszyn-Pynka M, Pynka S, Boron-Kaczmarska A, Pilarska K (2005) Serum leptin and adiponectin concentrations in patients infected with human immunodeficiency virus type 1 (HIV-1) on antiretroviral therapy. Endokrynol Pol 56:19-24
26. Masaki T, Anan F, Shimomura T, Fujiki M, Saikawa Tand Yoshimatsu H (2012) Association between hippocampal volume and serum adiponectin in patients with type 2 diabetes mellitus. Metabolism. Epub ahead of print
27. McMurtray A, Nakamoto B, Shikuma C, Valcour V (2007) Small-vessel vascular disease in human immunodeficiency virus infection: the Hawaii aging with HIV cohort study. Cerebrovasc Dis 24:236-241 (Pubitemid 47295590)
28. Mulligan K, Yang Y, Wininger DA, Koletar SL, Parker RA, Alston-Smith BL, Schouten JT, Fielding RA, Basar MT, Grinspoon S (2007) Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio. AIDS 21:47-57 (Pubitemid 44912536)
29. Nannipieri M, Bonotti A, Anselmino M, Cecchetti F, Madec S, Mancini E, Baldi S, Santini F, Pinchera A, Rossi M, Ferrannini E (2007) Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to themetabolic state. Int J Obes (Lond) 31:1843-1848 (Pubitemid 350174629)
30. Oomura Y, Hori N, Shiraishi T, Fukunaga K, Takeda H, Tsuji M, Matsumiya T, Ishibashi M, Aou S, Li X, Kohno D, Uramura K, Sougawa H, Yada T, Wayner M, Sasaki K (2006) Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats. Peptides 11:2738-2749 (Pubitemid 44584418)
31. Otvos LJ, Haspinger E, La Russa F, Maspero F, Graziano P, Kovalszky I, Lovas S, Nama K, Hoffmann R, Knappe D, Cassone M, Wade J, Surmacz E (2011) Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnol 11:90
32. Ouchi N, Walsh K (2007) Adiponectin as an anti-inflammatory factor. Clin Chim Acta 380:24-30 (Pubitemid 46498041)
33. Ouedraogo R, Gong Y, Berzins B, Wu X, Mahadev K, Hough K, Chan L, Goldstein BJ, Scalia R (2007) Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest 117:1718-1726 (Pubitemid 46871356)
34. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 278:9073-9085 (Pubitemid 36800387)
35. Paruthi J, Gill N, Mantzoros CS (2013) Adipokines in the HIV/HAART-associated lipodystrophy syndrome. Metabolism 24:S0026-S0495
36. Pistell PJ, Gupta S, Knight AG, Domingue M, Uranga RM, Ingram DK, Kheterpal I, Ruiz C, Keller JN, Bruce-Keller AJ (2010a) Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice. Antiviral Res 88:334-342
37. Pistell PJ, Morrison CD, Gupta S, Knight AG, Keller JN, Ingram DK, Bruce-Keller AJ (2010b) Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol 219:25-32
38. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, Scherer PE, Ahima RS (2004) Adiponectin acts in the brain to decrease body weight. Nat Med 10:524-529 (Pubitemid 38667912)
39. Quinn TC (2008) HIV epidemiology and the effects of antiviral therapy on long-term consequences. AIDS Patient Care STDS 22(Suppl 3): S7-S12
40. Reagan-Shaw S, Nihal M, Ahmad N (2007) Dose translation from animal to human studies revisited. FASEB J 22:659-661
41. Rocha VZ, Libby P (2008) The multiple facets of the fat tissue. Thyroid 18:175-183 (Pubitemid 351271537)
42. Rodriguez-Pacheco F, Martinez-Fuentes AJ, Tovar S, Pinilla L, Tena- Sempere M, Dieguez C, Castaño JP, Malagon MM (2007) Regulation of pituitary cell function by adiponectin. Endocrinology 148:401-410 (Pubitemid 46023452)
43. Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS, Society-USA. IA (2002) Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr 31:257-275 (Pubitemid 35278626)
44. Siasos G, Tousoulis D, Kollia C, Oikonomou E, Siasou Z, Stefanadis C, Papavassiliou AG (2012) Adiponectin and cardiovascular disease: mechanisms and new therapeutic approaches. Curr Med Chem 19: 1193-1209
45. Sivakumar T, Mechanic O, Fehmie DA, Paul B (2011) Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials. HIV Med 12:453-462
46. Spooner LM, Olin JL (2012) Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy. Ann Pharmacother 46:240-247
47. Takahashi T, Saegusa S, Sumino H, Nakahashi T, Iwai K, Morimoto S, Kanda T (2005) Adiponectin replacement therapy attenuates myocardial damage in leptin-deficient mice with viral myocarditis. J Int Med Res 33:207-214 (Pubitemid 40372436)
48. Tan IL, McArthur JC (2012) HIV-associated neurological disorders: a guide to pharmacotherapy. CNS Drugs 26:123-134
49. Vachharajan IV, Cunningham C, Yoza B, Carson JJ, Vachharajani TJ, McCall C (2012) Adiponectin-deficiency exaggerates sepsis-induced microvascular dysfunction in the mouse brain. Obesity (Silver Spring) 20:498-504
50. Valcour VG, Sacktor NC, Paul RH, Watters MR, Selnes OA, Shiramizu BT, Williams AE, Shikuma CM (2006) Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii aging with HIV cohort. J Acquir Immune Defic Syndr 43:405-410 (Pubitemid 44737096)
51. Valcour V, Maki P, Bacchetti P, Anastos K, Crystal H, Young M, Mack W, Cohen M, Golub E and Tien P (2011) Insulin resistance and cognition among HIV-infected and HIV-uninfected adult women-the women's interagency HIV study. AIDS Res Hum Retroviruses. Epub ahead of print
52. van Wijk JP, Hoepelman AI, de Koning EJ, Dallinga-Thie G, Rabelink TJ, Cabezas MC (2011) Differential effects of rosiglitazone and metformin on postprandial lipemia in patients with HIV-lipodystrophy. Arterioscler Thromb Vasc Biol 31:228-233
53. Veloso S, Escoté X, Ceperuelo-Mallafré V, López-Dupla M, Peraire J, Viladés C, Domingo P, Castro A, Olona M, Sirvent JJ, Leal M, Vendrell J, Richart C, Vidal F (2012) Leptin and adiponectin, but not IL18, are related with insulin resistance in treated HIV-1-infected patients with lipodystrophy. Cytokine 58:253-260
54. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T (2003) Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278:40352-40363 (Pubitemid 37248604)
55. Wei W, Wan Y (2011) Thiazolidinediones on PPARγ: the roles in bone remodeling. PPAR Res 2011:867180
56. Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, de Oliveira AC P, Pumpradit W, Shlay JC, El-Sadr W, Price RW, Group. ISS (2010) Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology 75:864-873
57. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112:91-100 (Pubitemid 38056380)
58. Xu A, Yin S, Wong L, Chan KW, Lam KS (2004) Adiponectin ameliorates dyslipidemia induced by the human immunodeficiency virus protease inhibitor ritonavir in mice. Endocrinology 145:487-494 (Pubitemid 38183790)
59. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno N, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769 (Pubitemid 36735700)